David A. Siegel Virios Therapeutics, Inc. Put Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VIRI
# of Institutions
22Shares Held
681KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$50,1310.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$41,8720.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$12,6780.0% of portfolio
-
Mc Collum Christoferson Group LLC Amherst, NY42KShares$10,0800.01% of portfolio
-
Raymond James & Associates St Petersburg, FL30KShares$7,2000.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $4.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...